These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 19231807

  • 21. Insight into the oseltamivir resistance R292K mutation in H5N1 influenza virus: a molecular docking and molecular dynamics approach.
    Karthick V, Ramanathan K.
    Cell Biochem Biophys; 2014 Mar; 68(2):291-9. PubMed ID: 23794010
    [Abstract] [Full Text] [Related]

  • 22. Virology. Helping the resistance.
    Holmes EC.
    Science; 2010 Jun 04; 328(5983):1243-4. PubMed ID: 20522766
    [No Abstract] [Full Text] [Related]

  • 23. H274Y's Effect on Oseltamivir Resistance: What Happens Before the Drug Enters the Binding Site.
    Yusuf M, Mohamed N, Mohamad S, Janezic D, Damodaran KV, Wahab HA.
    J Chem Inf Model; 2016 Jan 25; 56(1):82-100. PubMed ID: 26703840
    [Abstract] [Full Text] [Related]

  • 24. Inhibition of viral group-1 and group-2 neuraminidases by oseltamivir: A comparative structural analysis by the ScrewFit algorithm.
    Calligari PA, Kneller GR, Giansanti A, Ascenzi P, Porrello A, Bocedi A.
    Biophys Chem; 2009 Apr 25; 141(1):117-23. PubMed ID: 19195766
    [Abstract] [Full Text] [Related]

  • 25. Recent advances in neuraminidase inhibitor development as anti-influenza drugs.
    Feng E, Ye D, Li J, Zhang D, Wang J, Zhao F, Hilgenfeld R, Zheng M, Jiang H, Liu H.
    ChemMedChem; 2012 Sep 25; 7(9):1527-36. PubMed ID: 22807317
    [Abstract] [Full Text] [Related]

  • 26. Understanding of known drug-target interactions in the catalytic pocket of neuraminidase subtype N1.
    Malaisree M, Rungrotmongkol T, Decha P, Intharathep P, Aruksakunwong O, Hannongbua S.
    Proteins; 2008 Jun 25; 71(4):1908-18. PubMed ID: 18175324
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Binding mechanism of H5N1 influenza virus neuraminidase with ligands and its implication for drug design.
    Gong K, Li L, Wang JF, Cheng F, Wei DQ, Chou KC.
    Med Chem; 2009 May 25; 5(3):242-9. PubMed ID: 19442214
    [Abstract] [Full Text] [Related]

  • 34. Drug resistance. A 'wimpy' flu strain mysteriously turns scary.
    Enserink M.
    Science; 2009 Feb 27; 323(5918):1162-3. PubMed ID: 19251605
    [No Abstract] [Full Text] [Related]

  • 35. Molecular mechanisms underlying oseltamivir resistance mediated by an I117V substitution in the neuraminidase of subtype H5N1 avian influenza A viruses.
    Takano R, Kiso M, Igarashi M, Le QM, Sekijima M, Ito K, Takada A, Kawaoka Y.
    J Infect Dis; 2013 Jan 01; 207(1):89-97. PubMed ID: 23053629
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.